What is the appropriate management for a patient with symptomatic second-degree atrioventricular (AV) block?

Management of Symptomatic Second-Degree AV Block

For symptomatic second-degree AV block, immediately administer atropine 0.5 mg IV (repeated every 3-5 minutes up to 3 mg total) while preparing for transcutaneous or transvenous pacing, as definitive treatment requires permanent pacemaker implantation in most cases.

Initial Assessment and Stabilization

First, determine if the bradycardia is truly causing the symptoms. Look specifically for:

• Acute altered mental status
• Hypotension (systolic BP <80 mmHg)
• Signs of shock or poor perfusion
• Ischemic chest pain
• Acute heart failure
• Escape ventricular arrhythmias

Simultaneously:

• Ensure adequate oxygenation (check for hypoxemia, which commonly causes bradycardia)
• Establish IV access
• Obtain 12-lead ECG to classify the block type
• Monitor blood pressure continuously 1

Critical Distinction: Location of Block

The management hinges on whether the block is at the AV nodal level (responds to atropine) versus infranodal/His-Purkinje level (does not respond to atropine):

AV Nodal Block (Type I/Mobitz I):

• Narrow QRS escape rhythm
• Often associated with inferior MI
• Atropine is effective 2

Infranodal Block (Type II/Mobitz II):

• Wide QRS escape rhythm
• Often associated with anterior MI
• Atropine is contraindicated (Class III) - may worsen the block 2
• Requires immediate pacing

Immediate Pharmacologic Management

For AV Nodal Level Block:

Atropine (first-line):

• Dose: 0.5 mg IV bolus
• Repeat every 3-5 minutes as needed
• Maximum total dose: 3 mg
• Critical warning: Never give <0.5 mg (paradoxically worsens bradycardia)
• Target heart rate: ~60 bpm, not higher 2, 1, 3

Important caveat: Use atropine cautiously in acute MI settings, as increased heart rate may worsen ischemia or extend infarct size 2

Alternative Agents (if atropine fails or contraindicated):

For hemodynamically unstable patients with low likelihood of coronary ischemia:

• Isoproterenol, dopamine, dobutamine, or epinephrine may be considered 3
• In acute inferior MI specifically: Aminophylline IV may be considered 3

Pacing Strategy

Transcutaneous Pacing:

• Reasonable for refractory symptomatic block as a bridge to transvenous pacing 3
• Apply patches immediately in high-risk patients
• Note: Associated with significant pain; not suitable for prolonged use 2

Transvenous Pacing Indications (Class II):

1. Symptomatic bradycardia unresponsive to atropine
2. Mobitz Type II block (regardless of symptoms due to high progression risk)
3. Bilateral bundle branch block
4. New bifascicular block with first-degree AV block
5. Hypotension (SBP <80 mmHg) unresponsive to drug therapy 2

Definitive Management: Permanent Pacing

Permanent pacemaker is indicated when:

1. Symptomatic second-degree AV block persists after reversible causes are addressed 3

2. Patient requires chronic antiarrhythmic or beta-blocker therapy: It is reasonable to proceed directly to permanent pacing without waiting for drug washout (Class IIa recommendation) 3. Recent evidence shows that true drug-induced AVB is rare, with high recurrence rates after drug discontinuation 4.

3. Infranodal block (Mobitz Type II): Requires pacing regardless of symptoms due to high risk of progression to complete heart block 5

4. Cardiac sarcoidosis: Proceed to permanent pacing (with defibrillator capability if needed) without waiting for reversibility 3

Common Pitfalls to Avoid

1. Don't give atropine for infranodal block - it won't work and delays appropriate pacing 2

2. Don't assume drug-induced block is reversible - especially in elderly patients on stable doses of necessary medications. Early permanent pacing is often appropriate 4

3. Don't wait for "drug washout" in patients on chronic stable antiarrhythmic therapy - recurrence rates are high 3, 4

4. Don't use atropine doses <0.5 mg - causes paradoxical bradycardia 2, 1, 6

5. Don't delay pacing if temporary pacing is needed - associated risks don't justify waiting 4

Special Considerations

• Vagally mediated AV block: Benign condition associated with sinus slowing; pacemaker not indicated in asymptomatic patients 7

• 2:1 AV block: Cannot be classified as Type I or II from surface ECG alone; may require electrophysiology study to localize block 5, 8

• Acute MI context: Type I block with inferior MI is usually AV nodal and may respond to atropine; Type II block with anterior MI is infranodal and requires pacing 2